Our blog!

Useful information and resources for our community.

Knowledge is power!

Bookmark this page as we frequently post interesting articles, research, medical studies and events that may be of interest to our community. Have a great article you’d like to share with us? Looking to promote a fundraiser or similar group? Please contact us!

 

Latest posts

Good King Charlie

cancer is the commonest cancer among men. In this country about 52,000 men are diagnosed with prostate cancer each year, that’s 144 every day. And 12,000 men die of prostate cancer every year. The latest figures show that one in eight men will be diagnosed with prostate cancer in their lifetime. Let’s hope the King isn’t that one.

read more

Prostate Cancer Awareness at the Goffstown Sports Dome 01/17/2024💙

read more

Appreciated contribution

The NHPCC board wishes to thank Thomas J. Aspinwall for his generous contribution. The funds will go to the Jeffrey Kantor Memorial Fund for Prostate Cancer Research at the Dartmouth Cancer Center.

read more

News You Can Use – August 2021

mpMRI Misses Few Significant Prostate Cancers in Re-Biopsied Men Obesity Linked to Lower Death Risk in mCRPC EAU 2021: De Novo Versus Recurrent Metastatic mHSPC: What Is the Role of Modern Imaging? EAU 2021: Phase 3 Study of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer (VISION) EAU 2021: TheraP Phase 2 Trial of Lu-PSMA-617 vs Cabazitaxel: Results and Contrasts to the VISION Study EAU 2021: Introduction and Setting the Stage: Prostate Cancer: cN+ in Newly...

read more

News You Can Use – April 2021

News & Information from Us Too While we all must remain safe and socially distant due to COVID-19 restrictions, it is important for everyone to continue to monitor and address their health concerns, and stay connected to others. Us TOO has virtual prostate cancer support groups that continue to meet regularly and host guest speakers. These meetings can be accessed by phone or by internet, and can be attended from any location. For a list of groups, please visit:...

read more

Hello world!

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

read more

BREAKING NEWS: FDA Approves Apalutamide (Erleada) for the treatment of metastatic hormone-sensitive prostate cancer

September 18, 2019 – Last night the U.S. Food and Drug Administration (FDA) approved apalutamide (Erleada) for the treatment of metastatic hormone-sensitive (aka, “castration-sensitive”) prostate cancer (mHSPC). Apalutamide has previously received FDA-approval for the treatment of non-metastatic castration-resistant prostate cancer (nmCRPC). PCF funded the initial synthesis of apalutamide at UCLA by chemist Michael Jung, PhD, in collaboration with prostate cancer physician-scientist Charles...

read more

New Hampshire Prostate Cancer Coalition Disclaimer of Liability

By accessing this website and accessing any or all of its content, you agree to accept and be bound by the following terms, conditions, disclaimers and understandings;

  • This web site is produced by the New Hampshire Prostate Cancer Coalition. Our intent is only to provide information and links to other resources about prostate cancer.
  • While the New Hampshire Prostate Cancer Coalition makes every effort to provide accurate prostate cancer information, the New Hampshire Prostate Cancer Coalition does not warrant or guarantee that the prostate cancer information on this New Hampshire Prostate Cancer Coalition website is true, complete, up-to-date or not misleading.
  • Some of the prostate cancer information contained herein is gathered from various web sites and other sources over which the New Hampshire Prostate Cancer Coalition has no control. The New Hampshire Prostate Cancer Coalition cannot and does not guarantee the accuracy of this information.
  • The prostate cancer information on this website is not advice. It is provided for informational purposes only.
  • The prostate cancer information on this website may change without notice at any time. Links to other websites may change or be removed at any time without notice.
  • If you are seeking medical advice, seek advice from your doctor or other licensed, healthcare professional. Do not attempt self-diagnosis of any medical problem or condition; seek professional medical advice. Do not delay, disregard or discontinue any medical treatment based on anything you may read on this website.
  • Talk to your doctor.

Awareness. Education. Early Detection. Support.

Thanks for a Great Night!

We'll see you next year!

Celebrating Celine

with Jenene Caramielo

 

To benefit the New Hampshire Prostate Cancer Coalition

 

at The Palace Theatre in Manchester, NH

Sign up for our mailing list

Email Signup
Name
Name
First
Last

New Hampshire Prostate Cancer Coalition believes that information about products and services that could benefit people with prostate cancer should be made available to all consumers so they may make informed decisions. Any references to specific products, services, organizations or claims made in any advertisements or sponsorships of New Hampshire Prostate Cancer Coalition does not constitute an endorsement or recommendation of that product or service. New Hampshire Prostate Cancer Coalition strongly urges you to consult with a qualified medical doctor when considering all options concerning prostate cancer treatment.

Awareness. Education. Early Detection. Support.

New Hampshire Prostate Cancer Coalition Mailing Address | 75 South Main Street,  #175 | Concord, NH 03301